Femtobiomed Inc. (XKON: 327610)
7,070.00
+10.00 (0.14%)
Sep 10, 2024, 9:00 AM KST
Femtobiomed Company Description
Femtobiomed Inc. engages in the development of cargo-free intracellular delivery platform.
The company, through its platform, CELLSHOT, is working on cell-based therapeutic pipelines. Its platform provides unprecedented approaches to cell therapeutics and cell biology research.
The company was founded in 2011 and is based in Seongnam-si, South Korea.
Femtobiomed Inc.
Country | South Korea |
Founded | 2011 |
Industry | Biological Products, Except Diagnostic Substances |
Contact Details
Address: D-510, 700, Pangyo-ro Seongnam-si, 13516 South Korea | |
Phone | 82 3 1628 8158 |
Website | femtobiomed.com |
Stock Details
Ticker Symbol | 327610 |
Exchange | Korea New Exchange |
Reporting Currency | KRW |
SIC Code | 2836 |